As knowledge is expanding very rapidly, future directions should be addressed to determine the biological mechanisms underlying non-pigmentary MC1R functions, evaluate the gene–gene and gene-environment interactions, and to incorporate MC1R variants into melanoma and NMSCs risk prediction models and test their effect on motivating risk-reducing behaviors as a cancer prevention strategy. This evidence concerns the gene MC1R and melanoma.